Zwi B.
- Country
- Belgium
- Department
- Hematology
Research Overview
- Evaluation of Atezolizumab and WT1 LAMP mRNA DC Vaccine in Combination with Platinum/Pemetrexed for Epithelioid Malignant Pleural Mesothelioma
- Evaluation of WT1 LAMP mRNA DC Vaccination Combined with Chemotherapy in First-Line Treatment of Malignant Pleural Mesothelioma
- Evaluation of WT1 LAMP mRNA DC Vaccine as Adjuvant Therapy in Pediatric High-Grade Glioma and Diffuse Intrinsic Pontine Glioma
Data & Insights
Has run more than one trial at 2 of 8 partner sites.
Specializations
Neuro-Oncology
This investigator specializes in developing innovative treatments for high-grade brain tumors, with particular focus on glioblastoma and pediatric gliomas. Their research integrates dendritic cell immunotherapy with conventional treatment approaches.
- Adult Glioblastoma Management
- Pediatric High-Grade Gliomas
- Diffuse Intrinsic Pontine Glioma
The research encompasses both adult and pediatric patient populations, exploring personalized immunotherapy approaches.
Thoracic Oncology
The investigator conducts research in malignant pleural mesothelioma, focusing on combining immunotherapy approaches with standard treatments. Their work includes studying the integration of PD-L1 inhibitors with dendritic cell vaccination.
- Epithelioid Mesothelioma Treatment
- First-line Immunotherapy Strategies
- Combination Therapy Approaches
Their research explores novel therapeutic combinations for mesothelioma treatment.
Hematologic Oncology
The investigator focuses on developing treatments for acute myeloid leukemia, particularly utilizing dendritic cell vaccination strategies. Their research aims to prevent disease relapse in adult patients.
- Post-Remission Strategies
- Relapse Prevention
- Adult AML Treatment
The research emphasizes immunotherapeutic approaches in blood cancer treatment.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.